Pediatric Management
References :
Guidelines for the management of asthma are not intended to impose a standard of care.
They provide the basis for rational decisions in the management of asthma.
FeNO, fractional exhaled nitric oxide.
ICS, inhaled corticosteroid; LABA, long-acting beta agonist; MART, maintenance and reliever therapy (ICS-formoterol as both maintenance and reliever); SABA, short-acting beta agonist.
ACQ, asthma control questionnaire; AQLQ, asthma quality of life questionnaire; c-ACT, childhood asthma control test; EOS, eosinophils; FeNO, fractional exhaled nitric oxide; IgE, immunoglobulin E.
1. McGeachie MJ, et al. N Engl J Med. 2016;374:1842-1852.
2. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2024. Accessed June 6, 2024. https://ginasthma.org/reports/
3. Fuchs O, et al. Lancet Respir Med. 2017;5(3):224-234.
4. Lanz MJ, et al. Pediatr Pulmonol. 2019;54(3):348-357.
5. Pike KC, et al. Arch Dis Child. 2018;103(4):392-397.
VESTIGE Trial Results: Dupilumab in Type 2 Asthma
This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.
